Skip to content
Screener

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.74B+7.4%
Danaher logo
DanaherDHR
$870M+56.8%
Azenta logo
AzentaAZTA
$2.46M+105%
Agilent Technologies logo
Agilent TechnologiesA
$339M+57.7%
Illumina logo
IlluminaILMN
$207M-11.9%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$55.43M-59.6%

Segments

By segment

See full
Reportable Segment-$44.02M-11.9%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$7.21B+361%
Enterprise value$7.2B+396%
P/S17.6×+13.3×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Other income (expense), net[1]175(394)646(487)
Loss before income taxes$(43,978)$(39,153)$(74,232)$(70,651)
Income tax expense(43)(175)(296)(271)
Net loss$(44,021)$(39,328)$(74,528)$(70,922)
Other comprehensive loss:
Change in unrealized gain (loss) on investments$(85)$30$(67)$97
Foreign currency translation adjustment17(25)5543
Comprehensive loss$(44,089)$(39,323)$(74,540)$(70,782)

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's net income?
Twist Bioscience Corporation (TWST) reported net income of -$44.02M in Q1 2026.
How has Twist Bioscience Corporation's net income changed year-over-year?
Twist Bioscience Corporation's net income decreased by 11.9% year-over-year, from -$39.33M to -$44.02M.
What is the long-term trend for Twist Bioscience Corporation's net income?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's net income has grown at a -15.5% compound annual growth rate (CAGR), from -$152.1M to -$77.67M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Twist Bioscience Corporation's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude